Akili Strikes $125m Digital Med Deal With Japanese Partner
Executive Summary
PureTech Health's Akili has announced a $125m partnership with Japanese pharmaceutical company Shionogi to commercialize two of its digital therapeutics in Japan and Taiwan.
You may also be interested in...
Kids, Time To Play Your Medicine: Akili Prepares Launch Of EndeavorRx Video Game For ADHD
After being first to receive FDA clearance for a prescription-only software to treat ADHD and raising total funding of $230m, Akili plans a US launch in 2022 while targeting other indications.
Kids, Time To Play Your Medicine: Akili Prepares Launch Of EndeavorRx Video Game For ADHD
After being first to receive FDA clearance for a prescription-only software to treat ADHD and raising total funding of $230m, Akili plans a US launch in 2022 while targeting other indications.
Expert Panel Discusses Trends In Digital Health Investment
An expert panel at the AdvaMed MedTech Conference in San Francisco discussed trends in digital health investment including market opportunities and regulatory and reimbursement challenges.